Search | IOVS | ARVO Journals

Showing 1 – 20 of 30

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Evidence of epithelial remodeling but not epithelial mesenchymal transition in vernal keratoconjunctivitis.

Elena Salami; Umberto Rosani; Philippe Daull; Fabiano Cavarzeran; Jean-Sebastien Garrigue; Antonino Di Stefano; Brun Paola; Andrea Leonardi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):965 – A0434. doi:

ARVO Annual Meeting Abstract June 2022

Onset of Improvement in Signs and Symptoms of Vernal Keratoconjunctivitis (VKC) in Patients Treated with Cyclosporine A Cationic Emulsion (CsA CE) in the NOVATIVE Study

Andrea Leonardi; Serge Doan; Pierre-Jean Pisella; Mourad Amrane; Dahlia Ismail; Dominique Bremond-Gignac

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):892 – A0256. doi:

ARVO Annual Meeting Abstract June 2020

Conjunctival microbiota in vernal keratoconjunctivitis: metagenomic analysis

Andrea Leonardi; Umberto Rosani; Rocco Luigi Modugno; Fabiano Cavarzeran; Paola Brun

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3224. doi:

ARVO Annual Meeting Abstract June 2020

The Role of Autophagy and Inflammatory Mediators in Vernal Keratoconjunctivitis

Rocco Luigi Modugno; Paola Brun; elena tarricone; antonino di stefano; elena mattiuzzo; parvaneh mehrbod; saeid ghavami; Andrea Leonardi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4062. doi:

ARVO Annual Meeting Abstract July 2019

Conjunctival transcriptome profiling in vernal keratoconjunctivitis

Andrea Leonardi; Philippe Daull; Paola Brun; Rocco Luigi Modugno; Jean-Sebastien Garrigue

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6248. doi:

ARVO Annual Meeting Abstract July 2019

Safety and Tolerability of Topical Cyclosporine A Cationic Emulsion in Patients With Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Pooled Results of the NOVATIVE and VEKTIS Trials

Dominique Bremond-Gignac; Pasquale Aragona; Serge Doan; Mourad Amrane; DAHLIA ISMAIL; Jesús Montero; János Németh; Andrea Leonardi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6710. doi:

ARVO Annual Meeting Abstract July 2018

Topical Cyclosporine A 1 mg/mL Cationic Emulsion Yields Improvements in Signs of Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Results of the Phase III VEKTIS Study

Serge Doan; Andrea Leonardi; Mourad Amrane; Dahlia Ismail; Jesus Montero; Pasquale Aragona; Janos Nemeth; Dominique Brémond-Gignac

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5572. doi:

ARVO Annual Meeting Abstract June 2017

Topical Ciclosporin A 1 mg/mL Cationic Emulsion in the Treatment of Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Results of the Phase III VEKTIS Study

Andrea Leonardi; Serge Doan; Mourad Amrane; Dahlia Ismail; Jesus Montero; VVL Narasimha Rao; Janos Nemeth; Dominique Bremond-Gignac

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):541. doi:

ARVO Annual Meeting Abstract September 2016

Pooling of two randomized Phase III clinical trials of ciclosporin 1 mg/mL cationic emulsion (CsA CE) as a treatment for severe keratitis in patients with dry eye disease (DED)

Elisabeth Messmer; Andrea Leonardi; Mourad Amrane; Dahlia Ismail; Francisco C Figueiredo; Christophe Baudouin

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2871. doi:

ARVO Annual Meeting Abstract September 2016

Conjunctival transcriptome changes in vernal keratoconjunctivitis

Andrea Leonardi; Philippe Daull; Jean-Sebastien Garrigue; Elena Tarricone; Mylene Docquier; Paola Brun

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):302. doi:

ARVO Annual Meeting Abstract September 2016

Safety and efficacy of ciclosporin 1 mg/mL cationic emulsion (CsA CE) over 12 months in patients with severe dry eye disease (DED) in the SANSIKA Phase III trial

Gysbert B Van Setten; Francisco C Figueiredo; Andrea Leonardi; Mourad Amrane; Jean-Sebastien Garrigue; Dahlia Ismail; Christophe Baudouin

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2865. doi:

ARVO Annual Meeting Abstract September 2016

NEUROPATHIC OCULAR PAIN ASSESSMENT

Daniela Lazzarini; Alvise La Gloria Valerio; Iva Angela Fregona; Anna Mocellin; Edoardo Midena; Andrea Leonardi

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6165. doi:

ARVO Annual Meeting Abstract June 2015

A new grading scale score for corneal staining in patient with vernal keratoconjunctivitis

Alvise La Gloria Valerio; Daniela Lazzarini; Aurora Bertoncello; Angela Castegnaro; Iva Fregona; Andrea Leonardi

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5631. doi:

ARVO Annual Meeting Abstract June 2015

TEAR FLUID N-GLYCAN PROFILING TO INVESTIGATE BIOMARKERS IN VERNAL AND ATOPIC KERATOCONJUNCTIVITIS

Andrea Leonardi; Claudia Tosto; Angela Messina; Angelo Palmigiano; Rosaria Ornealla Bua; Donata Agata Romeo; Luisa Sturiale; Domenico Garozzo

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5875. doi:

Multidisciplinary Ophthalmic Imaging February 2015

Small Fiber Peripheral Neuropathy in Wilson Disease: An In Vivo Documentation by Corneal Confocal Microscopy

PDF

Giacomo Carlo Sturniolo; Daniela Lazzarini; Ottavia Bartolo; Marianna Berton; Andrea Leonardi; Iva Angela Fregona; Raffaele Parrozzani; Edoardo Midena
TAGS: cornea, hepatolenticular degeneration, microscopy, confocal, neuropathy, small-fiber
Invest. Ophthalmol. Vis. Sci.. 2015; 56(2):1390-1395. doi: https://doi.org/10.1167/iovs.14-15004

ARVO Annual Meeting Abstract April 2014

Allergic conjunctivitis: a national cross-sectional study

Angela Castegnaro; Federico Piliego; Daniela Lazzarini; Alvise La Gloria Valerio; Paolo Mattana; Iva A Fregona; Andrea Leonardi

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2491. doi:

ARVO Annual Meeting Abstract April 2014

Higher eccentricity of the LED source in photorefraction extends the range of measurement to high ametropias

Mario Angi; Oren M Feuerman; Andrea Leonardi

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):435. doi:

ARVO Annual Meeting Abstract April 2014

Cornea transcriptome changes induced by Atmospheric-Pressure Cold Plasma for the treatment of ocular surface infections

Andrea Leonardi; Elena Tarricone; Umberto Rosani; Matteo Zuin; Emilio Martines; Paola Venier; Paola Brun

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6264. doi:

ARVO Annual Meeting Abstract March 2012

Corneal Confocal Microscopy In Active And Non-active Vernal Keratoconjunctivitis

Massimo Bortolotti; Daniela Lazzarini; Angela Castegnaro; Federico Piliego; Iva Fregona; Edoardo Midena; Andrea Leonardi

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):93. doi:

ARVO Annual Meeting Abstract March 2012

Identification of The Anti-Inflammatory Annexin-A1 Protein in Tears of Normal Subjects and Association of its Cleaved-Inactive Form with Active Vernal Keratoconjunctivitis Patients

Samia Yazid; Andrea Leonardi; Virginia Calder; Roderick Flower

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6280. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Evidence of epithelial remodeling but not epithelial mesenchymal transition in vernal keratoconjunctivitis.

Onset of Improvement in Signs and Symptoms of Vernal Keratoconjunctivitis (VKC) in Patients Treated with Cyclosporine A Cationic Emulsion (CsA CE) in the NOVATIVE Study

Conjunctival microbiota in vernal keratoconjunctivitis: metagenomic analysis

The Role of Autophagy and Inflammatory Mediators in Vernal Keratoconjunctivitis

Conjunctival transcriptome profiling in vernal keratoconjunctivitis

Safety and Tolerability of Topical Cyclosporine A Cationic Emulsion in Patients With Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Pooled Results of the NOVATIVE and VEKTIS Trials

Topical Cyclosporine A 1 mg/mL Cationic Emulsion Yields Improvements in Signs of Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Results of the Phase III VEKTIS Study

Topical Ciclosporin A 1 mg/mL Cationic Emulsion in the Treatment of Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Results of the Phase III VEKTIS Study

Pooling of two randomized Phase III clinical trials of ciclosporin 1 mg/mL cationic emulsion (CsA CE) as a treatment for severe keratitis in patients with dry eye disease (DED)

Conjunctival transcriptome changes in vernal keratoconjunctivitis

Safety and efficacy of ciclosporin 1 mg/mL cationic emulsion (CsA CE) over 12 months in patients with severe dry eye disease (DED) in the SANSIKA Phase III trial

NEUROPATHIC OCULAR PAIN ASSESSMENT

A new grading scale score for corneal staining in patient with vernal keratoconjunctivitis

TEAR FLUID N-GLYCAN PROFILING TO INVESTIGATE BIOMARKERS IN VERNAL AND ATOPIC KERATOCONJUNCTIVITIS

Small Fiber Peripheral Neuropathy in Wilson Disease: An In Vivo Documentation by Corneal Confocal Microscopy

Allergic conjunctivitis: a national cross-sectional study

Higher eccentricity of the LED source in photorefraction extends the range of measurement to high ametropias

Cornea transcriptome changes induced by Atmospheric-Pressure Cold Plasma for the treatment of ocular surface infections

Corneal Confocal Microscopy In Active And Non-active Vernal Keratoconjunctivitis

Identification of The Anti-Inflammatory Annexin-A1 Protein in Tears of Normal Subjects and Association of its Cleaved-Inactive Form with Active Vernal Keratoconjunctivitis Patients

To View More...

You must be signed into an individual account to use this feature.